Skip to main content
Natural Capsules Ltd. logo

Natural Capsules Ltd. — Investor Relations & Filings

Ticker · NATCAPSUQ ISIN · INE936B01015 LEI · 335800JVYFZWBNKMS446 BSE.NS Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS NATCAPSUQ

About Natural Capsules Ltd.

https://www.naturalcapsules.com

Natural Capsules Ltd. is a specialized manufacturer of hard capsules catering to the pharmaceutical and nutraceutical sectors. The company produces a wide range of products, including hard gelatin capsules and vegetarian alternatives such as HPMC (Hydroxypropyl Methylcellulose) capsules. Its manufacturing capabilities extend to specialized variants like liquid-fill capsules and preservative-free options. The company emphasizes adherence to international quality standards and Good Manufacturing Practices (GMP) to ensure product safety and efficacy. By leveraging advanced technology in capsule shell production, it serves a global clientele of pharmaceutical formulators and dietary supplement providers. The core focus remains on providing high-quality delivery systems for oral dosage forms, supporting diverse therapeutic and nutritional applications.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015. Please find enclosed the Annual Secretarial Compliance Report dated May 27, 2026 for the FY ended March 31, 2026 issued by Mr. ....
Regulatory Filings Classification · 90% confidence The document is titled “Annual Secretarial Compliance Report” under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, prepared by a Practicing Company Secretary and addressed to stock exchanges. It is a statutory compliance certificate/attestation rather than a financial report itself. Under the certification rule and given it is a compliance document, it should be classified as a general regulatory filing.
2026-05-28 English
Change in Company Secretary/Compliance Officer
Board/Management Information Classification · 85% confidence The filing is an “Outcome of Board Meeting” under SEBI regulations – communicating board approvals (audited financial results, director re-appointments, auditor appointments, ESOP share allotment, etc.) and disclosing management changes and capital allotment. It is not itself a full Annual Report or standalone audit report, nor solely an earnings or share issue release, but primarily a board/management announcement. Therefore it best fits the Board/Management Information category (MANG).
2026-05-27 English
Appointment of Mr. Akshay Dutta (M.No. A80481) as Company Secretary and Compliance Officer of the Company w.e.f. May 27, 2026.
Board/Management Information Classification · 75% confidence The document is an official stock‐exchange filing under SEBI LODR regulations titled “Outcome of Board Meeting.” It lists board approvals (audited financial results), director re‐appointment, appointment of internal auditor and company secretary, and ESOP share allotment—all typical board/management announcements rather than the full annual report or proxy materials. This aligns with Board/Management Information (MANG).
2026-05-27 English
Natural Biogenex Private Limited (Material Subsidiary) at its BM held on May 27, 2026, has approved right issue of 11,11,200 equity shares of Rs. 10/-
Share Issue/Capital Change Classification · 96% confidence The document is an official stock exchange filing under SEBI LODR Regulation 30(9) notifying the approval of a rights issue of equity shares. This is an announcement of a new share issue (capital change). It does not present full financial results or minutes but specifically details the share issuance approval, fitting the ‘Share Issue/Capital Change’ category.
2026-05-27 English
General Updates
Share Issue/Capital Change Classification · 90% confidence The document is an exchange filing under SEBI LODR Regulation 30(9) notifying approval of a rights issue of equity shares by the company’s material subsidiary. It is neither a full financial report nor a simple report publication notice but an announcement of a new share issue (capital change). This aligns with the Share Issue/Capital Change category (SHA).
2026-05-27 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 86% confidence The document is an official exchange filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It summarizes the outcomes of a board meeting (approval of audited financial results, appointments/re-appointments of directors and officers, ESOP share allotment) and includes compliance declarations under Regulation 33(3)(d). It does not itself present full financial statements (it refers to annexures) and primarily serves as a regulatory announcement/compliance disclosure to stock exchanges. This fits the General Regulatory Filings (RNS) category.
2026-05-27 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.